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Importin αPolo-like kinase 1 plays an essential role in mitosis and cytokinesis. Expression and nuclear localization of
Plk1 during the S phase are necessary for its functions. Although it was reported that a bipartite nuclear
localization signal located at the N-terminal kinase domain is required for nuclear import of Plk1, Plk1
carrying mutations in the polo box I of the polo box domain exhibited increased cytoplasmic accumulation.
We further showed that the polo box domain was able to confer nuclear import of β-galactosidase in vivo
and GST–EGFP in vitro. The import carriers transportin and importin α were found to interact with the polo
box domain directly in a Ran–GTP sensitive manner. These results indicate the presence of a nuclear
localization signal in the polo box domain. A 38 amino acid sequence with the function of nuclear localization
signal was identiﬁed to interact with transportin. Our ﬁndings demonstrated that a transportin-dependent
nuclear localization signal is present in the polo box domain of Plk1, possibly required for efﬁcient nuclear
import. Showing little similarity to the M9 sequence, the 38 amino acid sequence identiﬁed here likely
represents a novel nuclear localization signal.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Polo-like kinase 1 (Plk1) is a conserved kinase playing essential
regulatory roles during mitosis and cytokinesis [1,2]. The structure of
Plk1 consists of the N-terminal kinase domain and the C-terminal
conserved polo box domain (PBD) [3]. The PBD is the substrate-
binding domain that recognizes phosphorylated epitopes [4,5]
although it was suggested that an alternative binding mechanism is
utilized for recognizing Cdc25C [6]. Expression of Plk1 is regulated
through the cell cycle, initiated during the S phase and peaked at the
G2/M phase junction [7], and the kinase activity of Plk1 is activated
upon phosphorylation of serine 137 and threonine 210 [8]. In
addition, the function of Plk1 is also regulated by spatial and temporal
localization to the cellular structures through the interaction of the
PBD with its substrate proteins [3]. During mitosis, Plk1 is speciﬁcally
localized to kinetochores at the prophase, remaining in the mid-body
after the metaphase–anaphase transition, and associated with the
actomyosin ring during cytokinesis [3,9]. Plk1 produced during the
interphase is localized in the cytoplasm as well as in the nucleus, and
the cells expressing mutant Plk1 with impaired nuclear localization
during the S phase are defective in the mitotic process [10]. Thus,e and Institute of Molecular
rsity Rd, Min-Hsiung, Chia-Yi
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l rights reserved.proper nuclear localization of Plk1 during the interphase is essential
for initiation and progression of mitosis.
Proteins targeted to the nucleus are transported through the
nuclear envelope in a post-translational process [11]. The signal
sequences carried by the proteins required for nuclear import are
referred to as nuclear localization signals (NLSs). The classic NLS,
consisting of one or two clusters of basic amino acid residues, are
recognized by importin α [12,13] which in turn interacts with
importin β to form the import complex [12]. However, recent ﬁndings
indicated that some proteins require only importin α [14] or import β
[15] for their nuclear import, suggesting a more ﬂexible NLS
recognition and transport mechanism for importin α and importin
β. Other nuclear import signals include the M9 sequence of hetero-
nuclear ribonucleoprotein A1 (hnRNP A1) recognized by transportin
[16,17] and the RS domain of the SR proteins recognized by
transportin-SR and transportin-SR2 [18,19]. Translocation of the
carrier-cargo complex through the nuclear pore complex does not
require additional input of energy in the form of ATP hydrolysis.
Instead, the energy is used to maintain nuclear Ran in the GTP-
charged status [20–22]. In the nucleus, the cargo protein is released
from the import carrier by the conformational change caused by the
binding of Ran–GTP to the carrier [23,24].
It has been shown that Plk1 is targeted to the nucleus through a
bipartite nuclear localization signal located at the N-terminal kinase
catalytic domain [10]. However, in the course of our previous study
identifying the interaction between HPV-5 E2 and Plk1 [25], we
discovered that Plk1 carryingmutant polo box domain is accumulated
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demonstrate that the polo box domain of Plk1 exhibits the ability to
direct protein nuclear import and that a 38 amino acid sequence in the
polo box domain functions as a NLS. Sharing little similarity with
known NLSs, this 38 amino acid sequence likely represents a novel
NLS.
2. Materials and methods
2.1. Plasmids and plasmid construction
The coding sequence of full length (WT) Plk1 obtained by RT-PCR
using total RNA extracted from HeLa cells was inserted to pBluescript
II KS+ (Agilent Technologies, Santa Clara, CA). The sequence encoding
amino acid 413 to 416 of Plk1 was removed or changed to alanine
residues using the QuikChange site-directed mutagenesis kit (Agilent
Technologies) to create the ΔKWVD and the KWVD4A mutants. The
sequences for WT, ΔKWVD, and KWVD4A Plk1 were subsequently
cloned to pEGFP-C1 (BD Biosciences, San Diego, CA) to create pEGFP-
WT, pEGFP-ΔKWVD, and pEGFP-KWVD4A, respectively. To construct
pFLAG-β-gal, the coding sequence of β-galactosidase from pCH110
(GE Healthcare, Piscataway, NJ) was subcloned to pFLAG-CMV2
(Sigma-Aldrich, St. Louis, MO). The coding sequences for WT Plk1
and the kinase domain-deleted Plk1 (ΔKD, residues 307–603) were
cloned to pFLAG-β-gal to create pFLAG-WT-β-gal and pFLAG-ΔKD-β-
gal. The sequence encoding amino acid residues 396 to 433 of Plk1
(NH2-RQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVG-COOH)
was inserted into pFLAG-β-gal to create pFLAG-38-β-gal.
To create pGST–EGFP, the sequence encoding EGFP was cloned
from pEGFP-C1 to pGEX-4T3. The sequence encoding ΔKD was then
inserted to pGST–EGFP, pET15b+, and pGEX-2T to create pGST–ΔKD–
EGFP, pET-ΔKD, and pGST–ΔKD. The vectors for expressing recombi-
nant wild type Ran and Ran with Q69L mutation (RanQ69L) were
kindly provided by I. W. Mattaj (European Molecular Biology
Laboratory, Heidelberg). The plasmid pGST–impα for the expression
of GST–importin α was a gift from Y. Yoneda (Osaka University,
Osaka) [26]. pGST-TRN obtained from W. Y. Tarn (Academia Sinica,
Taipei) [27] was constructed by inserting the sequence of transportin
kindly provided by B. R. Brian (Duke University, NC) [17] to pGEX-2T.
2.2. Puriﬁcation of recombinant proteins
pET-ΔKD was transformed to Rosetta 2(DE3) (Merck KGaA,
Darmstadt, Germany), and hexahistidine tagged ΔKD protein was
puriﬁed using HIS-select nickel afﬁnity agarose (Sigma-Aldrich). GST,
GST–ΔKD, GST–importinα, and GST–transportin expressed in Rosetta
2 (Merck KGaA) were puriﬁed using glutathione Sepharose 4B (GE
Healthcare). Puriﬁed proteins were dialyzed against transport buffer
containing 20 mM HEPES (pH 7.3), 110 mM potassium acetate, 2 mM
magnesium acetate, 5 mM sodium acetate, 2 mM dithiothreitol, 1 mM
EGTA, and 8.7% glycerol. Hexahistidine tagged Ran and RanQ69L were
puriﬁed from Rosetta 2(DE3) co-transformedwith pRep4 according to
themethod described by Gorlich, et al. [28]. Puriﬁed Ran and RanQ69L
were dialyzed against 50 mM potassium phosphate (pH 7.0), 50 mM
KCl, 5 mM MgCl2, 1 mM β-mercaptoethanol, 8.7% glycerol, and
0.1 mM GDP for Ran or 0.1 mM GTP for RanQ69L. Before use, Ran and
RanQ69L were charged with 1 mMGDP and GTP at room temperature
for 30 min [29].
2.3. Transient transfection, synchronization of HeLa cells, and
preparation of cell extracts
HeLa and HEK293 cells were cultured in Dulbecco's modiﬁed
Eagle's medium (Hyclone, Logan, UT) supplemented with 10% fetal
bovine serum (Hyclone). Transfection of HeLa cells was achieved
using TransFast transfection reagent (Promega, Madison, WI). Forpreparing cell extracts from HeLa cells synchronized at speciﬁc stages
of the cell cycle, double thymidine block was performed. Brieﬂy, HeLa
cells were ﬁrst treated with 2 mM thymidine for 16 h. Two hours after
being released from the ﬁrst thymidine block, the cells were treated
with 0.5 mM nocodazole for 8 h, followed by a second thymidine
block for another 16 h. If required, transfection was carried out before
nocodazole treatment. At 0, 6, and 12 h after release from the second
thymidine block, the cell extracts were prepared by lysing the cells in
radioimmunoprecipitation assay (RIPA) buffer containing 10 mM
sodium phosphate (pH 7.2), 150 mMNaCl, 2 mM EDTA, 1% Nonidet P-
40, and protease inhibitor (Sigma-Aldrich) on ice for 10min. Insoluble
debris was removed by centrifugation at 4 °C, 1500 g for 10 min. To
fractionate the cells into the cytoplasmic and the nuclear extracts, the
cells were permeabilized in buffer A containing 10 mM HEPES (pH
7.9), 10 mM KCl, 1.5 mM MgCl2, 0.1% Nonidet P-40, and protease
inhibitor (Sigma-Aldrich) on ice for 5 min, followed by centrifugation
at 4 °C, 1400 g for 5 min. The supernatant was the cytoplasmic
fraction, and the pellet was resuspended in PBS of the same volume as
that of the cytoplasmic fraction. The nuclear and the cytoplasmic
extracts were analyzed by immunoblotting.
2.4. In vitro pull-down assay and Ran competition
For identiﬁcation of ΔKD binding nuclear import carriers, the cell
extract prepared in RIPA buffer was mixed with GST or GST–ΔKD and
incubated at 30 °C for 30 min. This was followed by precipitation of
GST fusion bait proteins using glutathione Sepharose 4B (GE
Healthcare) at 4 °C for 2 h. Proteins coprecipitated with the bait
protein were fractionated by SDS-polyacrylamide gel electrophoresis
(SDS-PAGE), followed by mass spectrometry identiﬁcation or by
immunoblotting. For Ran competition, GST fusion importin α or
transportin was incubated with hexahistidine tagged ΔKD in the
absence or the presence of Ran–GDP or of RanQ69L–GTP in transport
buffer containing 0.1% Nonidet P-40 at 30 °C for 30 min, followed by
precipitation of GST fusion bait proteins using glutathione Sepharose
4B (GE Healthcare) at 4 °C for 2 h. Matrix-bound ΔKD protein was
detected by immunoblotting using an anti-Plk1 antibody.
2.5. Immunoblotting
For immunoblotting, the protein extract obtained from HeLa cells
or from in vitro pull-down assay was separated in SDS-PAGE and
transferred to polyvinylidene diﬂuoride membrane (GE Healthcare).
The membrane was blocked in 5% skim milk in PBS containing 0.1%
tween-20. The monoclonal antibodies used for the detection of target
proteins were anti-EGFP (1:2,000, Roche Applied Science, Mannheim,
Germany), anti-β-galactosidase (1:2000, Promega), anti-lamin
(1:2000, Millipore, Billerica, MA), anti-α-tubulin (1:4000, Thermo
Fisher Scientiﬁc, Fremont, CA), anti-GST (1:2000, Millipore), anti-
importin α (1:2000, BD Biosciences), anti-importin β (1:2000, BD
Biosciences), and anti-transportin (1:2000, BD Biosciences) antibo-
dies. The polyclonal antibodies were anti-transportin-SR2 antibody
(1:2000, a gift fromDr.W. Y. Tarn) [19] and anti-Plk1 antibody against
ΔKD Plk1 (1:2000, raised in our laboratory). The secondary antibodies
were horseradish peroxidase linked anti-mouse and anti-rabbit
antibodies (GE Healthcare). Chemiluminescence detection was
performed using Immobilon western HRP substrate (Millipore).
2.6. Indirect ﬂuorescence immunostaining
The protocol described earlier [30] for indirect ﬂuorescence
immunostaining was followed except 4% paraformaldehyde was
used for ﬁxation. EGFP fusion proteins were observed directly, and
α-tubulin was detected using an anti-α-tubulin antibody (1:500,
Thermo Fisher Scientiﬁc). β-galactosidase fusion proteins were
detected using an anti-β-galactosidase antibody (1:250, Promega).
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mouse antibody (1:500, Jackson Immunoresearch Laboratories, West
Grove, PA). After staining, the cells were ﬁxed in 1% paraformaldehyde
for 10 min. Cellular chromosomes were stained with 4′,6-diamidino-
2-phenylindole (DAPI). Fluorescence images were captured using a
Carl Zeiss LSM 510 laser scanning microscope.
2.7. In vitro import assay
The in vitro import assay was performed as described by Lai, et al.
[28] except rabbit reticulocyte lysate (Promega) was used. Brieﬂy,
HeLa cells grown on glass slips were permeabilized in transport buffer
containing 30 μg/ml digitonin (Sigma-Aldrich) on ice for 5 min.
Permeabilized cells were washed with transport buffer and incubated
with 20 μl import reaction mixture under the indicated condition for
30 min. The 20 μl complete import reaction mixture contained 5 μl
rabbit reticulocyte lysate, 2 μl 10× ATP mixture, and the import
substrate in transport buffer [31]. The 10× ATP mixture is the energy
regenerating system described by Jakel and Gorlich [32], which
contained 0.5 mM ATP, 0.5 mM GTP, 10 mM creatine phosphate, and
50 mg/ml creatine kinase. After incubation, the slips were washed
with transport buffer, and the cells were ﬁxed in 4% paraformalde-
hyde at room temperature for 30 min. Capture of the ﬂuorescence
images was made using a Nikon 80i microscope.
3. Results
3.1. Mutations in the polo box domain result in cytoplasmic
accumulation of Plk1
We previously reported that Plk1 is an interacting protein of the
human papillomavirus type 5 E2 [25]. During the course of the study, a
mutant of Plk1 with deletion of amino acid residue 413 to 416
(ΔKWVD)was produced to disrupt the substrate recognition ability ofFig. 1.Mutations of the polo box domain lead to cytoplasmic accumulation of Plk1. (A) The sc
HeLa cells transiently expressing EGFP-WT (panel A), EGFP-ΔKWVD (panel D), or EGFP-KWV
an anti-α-tubulin antibody (panels B, E, and H). The nuclei were stained by DAPI (panels, C,
The pattern of nucleocytoplasmic distribution of Plk1 in non-synchronized HeLa cells was as
(N=C). The number of the cells with each type of the distribution pattern was determinedPlk1 (Fig. 1A). While the WT Plk1 exhibits characteristic localization
to the spindle pole (Fig. S1A, panel A), the mitotic chromosomes (Fig.
S1A, panel A), and the cytokinetic neck (Fig. S1B, panel A), the
ΔKWVDmutant failed to localize to these cellular structures (Fig. S1A,
panel E; Fig. S1B, panel D). Besides the failure to target to the speciﬁc
cellular structures, Plk1 with the ΔKWVD mutation also displayed
cytoplasmic accumulation in a signiﬁcant percentage of the inter-
phase cells (Fig. 1B, panel D). In contrast, the wild type (WT) Plk1 was
mainly localized in the nuclei of the interphase cells (Fig. 1B, panel A),
implying that the ΔKWVD mutation led to defect in intracellular
distribution of Plk1. A potential effect of the ΔKWVD mutation is the
disruption of the overall structure of the polo box domain, and the
misfolding of PBD may consequently exert unintended effect to the
nucleocytoplasmic distribution of Plk1. To eliminate this possibility,
we mutated the four amino acid residues deleted in the ΔKWVD
mutant into alanine residues to preserve the length of the PBD. The
resulted KWVD4A mutant was still targeted to the cytokinetic neck
(Fig. S1B, panel G) but nevertheless exhibited cytoplasmic accumu-
lation in the interphase cells (Fig. 1B, panel, G).
To more accurately estimate the effect of the ΔKWVD and the
KWVD4Amutations to the nucleocytoplasmic distribution of Plk1, we
observed and determined the signal strength of transiently expressed
WT, ΔKWVD, and KWVD4A Plk1 in the nucleus and in the cytoplasm
in non-synchronized HeLa cells from randomly selected views under
microscope (Fig. S2). The percentages of the cells with stronger
nuclear accumulation, with stronger cytoplasmic accumulation, and
approximately equal nucleocytoplasmic distribution in the total
population were calculated. The result shown in Fig. 1C indicated
that both ΔKWVD and KWVD4A demonstrated signiﬁcant negative
impact to the nuclear localization of Plk1. Since neither the ΔKWVD
nor the KWVD4A mutation was expected to disable the bipartite NLS
located at the N-terminal kinase domain, our result implied that
localization of Plk1 in the nuclei during the interphase requires
participation of the PBD.hematic depicts the structures of EGFP-WT, EGFP-ΔKWVD, and EGFP-KWVD4A Plk1. (B)
D4A (panel G) were ﬁxed in 4% paraformaldehyde, followed by immunostaining using
F, and I). The ﬂuorescent images were taken using a confocal scanning microscope. (C)
signed as nuclear dominant (NNC), cytoplasmic dominant (NbC), or evenly distributed
and presented as the percentage of the total population.
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Since the mutant Plk1 examined in Fig. 1 still carries the NLS
located at the kinase domain, it is not clear whether the polo box
domain, in the absence of the N-terminal NLS, is transported actively
into the nucleus. In order to determine the cellular localization of the
PBD, we took advantage of the exclusive cytoplasmic localization of β-
galactosidase. A vector to express FLAG tagged β-galactosidase (FLAG-
β-gal) in vivo was constructed, and the coding sequence of either the
wild type Plk1 (WT) or the truncated Plk1 lacking the kinase domain
(ΔKD) was inserted to the reporter plasmid to express β-galactosi-
dase fusion proteins (FLAG-WT-β-gal and FLAG-ΔKD-β-gal) (Fig. 2A).
In addition, we also intended to determine whether the cellular
localization of these β-galactosidase fusion proteins is regulated by
the cell cycle. Hence, these β-galactosidase fusion proteins were
expressed in HeLa cells synchronized by double thymidine block, and
the localization of the β-galactosidase fusion proteins in the HeLa cells
0, 4, and 8 h after being released from the second thymidine block was
determined by nucleocytoplasmic fractionation followed by
immunoblotting.
The result showed that the control FLAG-β-gal was exclusively
localized in the cytoplasm (Fig. 2B, lanes 2, 4, and 6), indicating that
FLAG-β-gal lacks an NLS, and FLAG-WT-β-gal was imported to the
nucleus during the interphase (Fig. 2B, lanes 8, 10, and 12), as
previously reported [10]. On the other hand, FLAG-ΔKD-β-gal, lacking
the N-terminal bipartite NLS, was still imported to the nucleus (Fig.
2B, lanes 14, 16, and 18) although the efﬁciency appeared to be
somewhat lower than that of FLAG-WT-β-gal. However, if the NLS inFig. 2. Fusion of the PBD leads to nuclear import of β-galactosidase in vivo. (A) The schematic
after being released from double thymidine block, the HeLa cells expressing FLAG-β-gal (la
subject to nucleocytoplasmic fractionation. The levels of the β-galactosidase fusion protein
fractions were determined by immunoblotting with an anti-β-galactosidase antibody (top
using the anti-lamin (middle panel) and the anti-α-tubulin antibodies (bottom panel). (C) Th
and the percentages of the nuclear and cytoplasmic FLAG-β-gal, FLAG-WT-β-gal, and FLAGthe kinase domain is the only NLS in Plk1, FLAG-ΔKD-β-gal should be
exclusively localized in the cytoplasm. Since fusion of the PBD resulted
in the nuclear import of β-galactosidase, the result suggested that the
PBD is transported actively into the nucleus in vivo.
Quantiﬁcation of the protein levels in the blots shown in Fig. 2B
indicated increased nuclear localization of FLAG-WT-β-gal upon
progression of the cell cycle from the G1/S phase toward the G2/M
phase (Fig. 2C). In contrast, the level of FLAG-ΔKD-β-gal is increased
in the cytoplasm in the late interphase. It is possible that the NLS at the
kinase domain and the PBD exhibited distinct cell-cycle dependent
efﬁciency in nuclear import.
3.3. The polo box domain is actively transported into the nucleus in vitro
Next, an in vitro import assay was performed to provide additional
evidence that the PBD is transported into the nucleus. A vector was
ﬁrst constructed to produce GST–EGFP protein, and the coding
sequence of ΔKD was subsequently inserted between the sequences
of GST and EGFP to produce recombinant GST–ΔKD–EGFP. The
integrity of the recombinant GST–EGFP and GST–ΔKD–EGFP used in
the in vitro import assay was conﬁrmed by immunoblotting with the
antibodies against N-terminal GST and C-terminal EGFP (Fig. 3A). The
cytosolic factors required for nuclear import of the cargo proteins
were provided by rabbit reticulocyte lysate [31], and the complete
import mixture also included an energy regeneration system [32].
GST–EGFP incubated under the complete import mixture and normal
temperature remained in the cytoplasm, indicating that neither GST
nor EGFP carried NLS (Fig. 3B, panel A). On the contrary, GST–ΔKD–depicts the structures of FLAG-β-gal, FLAG-WT-β-gal, and FLAG-ΔKD-β-gal. (B) 0, 4, 8 h
nes 1 to 6), FLAG-WT-β-gal (lanes 7 to 12), or FLAG-ΔKD-β-gal (lanes 13 to 18) were
s in the cytoplasmic (odd-numbered lanes) and in the nuclear (even-numbered lanes)
panel). The nuclear and the cytoplasmic fractions were conﬁrmed by immunoblotting
e band intensities of the β-gal fusion proteins in the blots shown in (B) were measured,
-ΔKD-β-gal in the total protein in each time point are shown.
Fig. 3. The PBD is able to confer the ability of nuclear import in vitro. (A) The schematic
shows the structures of GST–EGFP and GST–ΔKD–EGFP used in the in vitro import
assay. Puriﬁed GST–EGFP (lanes 1 and 3) and GST–ΔKD–EGFP (lanes 2 and 4) were
conﬁrmed by immunoblotting using anti-GST (lanes 1 and 2) and anti-EGFP antibodies
(lanes 3 and 4). (B) The in vitro import assay was performed by incubating digitonin-
permeabilized HeLa cells with the import mixture at 37 °C for 30 min. In addition to the
reactions using a complete mixture for in vitro import of GST–EGFP (panel A) and
GST–ΔKD–EGFP (panel I), the reactions of incubating at 4 °C (panel C), of lacking ATP
(panel E), or of lacking reticulocyte lysate (panel G) were performed for GST–ΔKD–
EGFP. The nuclei of permeabilized HeLa cells were visualized by staining with DAPI
(panels B, D, F, H, and J).
Fig. 4. Transportin and importin α interact with the PBD. (A) The cell extract was
subject to an in vitro pull-down assay using GST (lane 1) and GST–ΔKD (lane 4) as bait,
and coprecipitated proteins were analyzed bymass spectrometry. The recombinant bait
proteins used in the assay are shown in lanes 2 and 3. Transportin, exportin-1, and Ran
were identiﬁed as the interaction proteins of the PBD. The peptide sequences identiﬁed
by mass spectrometry are shown for each protein. (B) The cell extracts prepared from
HeLa cells 0, 4, or 8 h after being released from the double thymidine block were subject
to an in vitro pull-down assay using GST (lanes 2, 5, and 8) or GST–ΔKD (lanes 3, 6, and
9) as the bait, followed by immunoblotting with the antibodies against transportin (top
panel), importin α (upper middle panel), importin β (lower middle panel), and
transportin-SR2 (bottom panel). Two percent of cell extracts in each pull-down assay
were also shown (lanes 1, 4, and 7).
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nuclear transport of GST–ΔKD–EGFP was inhibited by low tempera-
ture (Fig. 3B, panel C), lack of energy (Fig. 3B, panel E), or an absence
of cytosolic factors (Fig. 3B, panel G). Hence, the results of energy and
factor dependent nuclear transport indicated that GST–ΔKD–EGFP
was actively transported to the nuclei.
Taken together, these data strongly suggested that the PBD of Plk1
alone can be imported to the nucleus and that this function of the PBD
is required for efﬁcient import of Plk1. There are two plausible
molecular mechanisms underlying our observation. It is likely that an
additional NLS is located in the PBD, and this putative NLS is asimportant as the NLS at the kinase domain for mediating nuclear
import of Plk1. Alternatively, the PBD may facilitate nuclear import of
Plk1 by tethering to other proteins that are in transit to the nucleus.
Since it is equally possible for the ΔKWVD and the KWVD4A
mutations either to disable the putative NLS sequence or to disrupt
the substrate-binding activity of the PBD, the data described above is
not sufﬁcient to determine how the PBD participates in nuclear
import. Further experiments are required to determine which
mechanism is utilized by the PBD to facilitate the nuclear import of
Plk1.
3.4. Transportin and importin α interact with the polo box domain
If there is an unidentiﬁed NLS present at the PBD, an import carrier
will be required for recognition of this NLS directly. Hence, we set out
to identify the transport carrier responsible for import of the PBD. An
in vitro pull-down assay was performed using recombinant GST–ΔKD
protein as the bait to precipitate the interacting proteins from the cell
extract. The proteins coprecipitated with GST–ΔKD (Fig. 4A, lane 4)
were then identiﬁed by mass spectrometry. Among the interaction
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This result implicated transportin as the import carrier recognizing
the PBD.
To further conﬁrm the interaction of the PBD with transportin, an
in vitro pull-down assay was performed using the cell extracts
prepared from synchronized HeLa cells zero, four, or eight fours after
being released from double thymidine block. This was followed by
immunoblotting using the antibodies against transportin. In addition,
immunoblotting was performed using the antibodies against importin
α, importin β, or transportin-SR2 to determine whether there are
other PBD-recognizing import carriers not identiﬁed by mass
spectrometry. Due to lack of antibodies, the interaction of other
import carriers with the PBD was not examined. The result indicated
that transportin was speciﬁcally coprecipitated with GST–ΔKD (Fig.
4B, top panel, lanes 3, 6, and 9), supporting the result obtained by
mass spectrometry. Moreover, it appeared that that importin α also
interactedwith the PBD (Fig. 4B, uppermiddle panel, lanes 3, 6, and 9)
while transportin-SR2 or importin β showed no interaction with
GST–ΔKD (Fig. 4B, lower middle and bottom panels). Hence, our data
indicated that PBD is transported into the nucleus either by
transportin or by importin α. However, lack of the interaction
between the PBD and importin β implies either that binding of
importin α with the PBD may not be involved in nuclear import of
Plk1 or that importinα alone could be sufﬁcient tomediate the import
of Plk1 in a similar manner to that of CaMKIV [14].
3.5. The interaction of transportin and importin α with the polo box
domain is direct and Ran–GTP sensitive
It is known that binding of Ran–GTPwith the import carriers in the
nucleus leads to the release of the cargo proteins [33]. Thus, an in vitro
pull-down assay using recombinant transportin, importin α, and Ran
was performed to determine whether the interaction of the PBD with
transportin and importin α is disrupted by GTP-charged Ran.
Moreover, we can also examine whether the binding of these two
carriers to the PBD is a direct interaction through this assay.
Hexahistidine tagged ΔKD was incubated with GST, GST–trans-
portin, or GST–importin α in the absence of Ran or in the presence of
Ran–GDP or RanG69L–GTP, followed by precipitation with glutathi-
one Sepharose. Matrix-bound ΔKD protein was analyzed by immu-
noblotting using an anti-Plk1 antibody. The result indicates that ΔKD
interacted directly with transportin and importin α in the absence of
Ran (Fig. 5A, lane 2; Fig. 5B, lane 2), and Ran–GDP was unable to
disrupt the interaction (Fig. 5A, lane 3; Fig. 5B, lane 3). In contrast,
ΔKD was released from transportin and importin α by the addition of
RanQ69L–GTP in a dosage dependent manner (Fig. 5A, lanes 4 to 6;Fig. 5. The interaction of transportin and importinαwith the PBD is direct and Ran–GTP
sensitive. (A) An in vitro pull-down assay was performed using GST–transportin to
precipitate hexahistidine tagged ΔKD. The reactions were performed in the absence of
Ran (lane 2), with 0.5 nmol Ran–GDP (lane 3), with 0.25 nmol RanQ69L–GTP (lane 4),
with 0.5 nmol RanQ69L–GTP (lane 5), or with 1 nmol RanQ69L–GTP (lane 6).
Coprecipitated ΔKDwas detected by immunoblotting using anti-Plk1 antibodies (upper
panel), and the bait GST–transportin were detected by staining with Coomassie blue
(lower panel). Twenty percent of input is shown in lane 1. (B) Similar experiment
described in (A) was performed for importin α.Fig. 5B, lanes 4 to 6), indicating that both transportin and importin α
met the criteria to interact with the PBD as an import carrier.
Direct interaction of the import carriers strongly suggests that an
unidentiﬁed NLS is present in the PBD. Hence, the mechanism that the
PBD facilitates nuclear import by tethering to other nuclear proteins
appears to be unlikely although this possibility is not completed ruled
out. Since the ΔKWVD and KWVD4A mutations lead to cytoplasmic
accumulation of Plk1, it suggests that these four amino acid residues
are part of the NLS sequence. Consequently, it is reasonable to
speculate that the NLS is located at the N-terminal sequence of polo
box domain and contains these four amino acid resides.
3.6. A novel nuclear localization signal is located in the polo box I of
the polo box domain
To examine whether the N-terminal sequence of polo box domain
is able to function as an NLS, we inserted the sequence encoding the
amino acid residues 396 to 433 to pFLAG-β-gal to produce pFLAG-38-
β-gal (Fig. 6A). Structurally, this 38 amino acid sequence forms the β1,
β2, and partial β3 of the polo box I as well as the two 310 helices
upstream of the polo box I [4,5]. The localization of FLAG-38-β-gal
expressed in HeLa cells was determined by nucleocytoplasmic
fractionation followed by immunoblotting. The result showed that
this sequence is able to direct nuclear import of β-galactosidase in
vivo (Fig. 6B, lane 3). Fluorescence immunostaining also showed
strong nuclear staining of 38-β-gal in HeLa cells (Fig. 6C, panel C) in
comparison of the cytoplasmic localization of β-galactosidase (Fig. 6C,
panel A). Hence, the result indicates that the sequence of amino acid
residues 396 to 433 is an NLS.
Our data in Fig. 5 showed that transportin and importin α are
capable of interacting directly with the PBD. To determine whether
transportin and importin α recognize this 38 amino acid sequence, an
in vitro pull-down assay was performed using recombinant carriers to
precipitate FLAG-38-β-gal expressed in vivo. While FLAG-β-gal was
not coprecipitated with any of the bait proteins (Fig. 6D, lanes 2 to 4),
transportin was able to precipitate signiﬁcant amount of FLAG-38-β-
gal (Fig. 6D, lane 8). On the other hand, it appears that importin α
showed very weak afﬁnity to the 38 amino acid NLS (Fig. 6D, lane 7).
The result indicated that transportin is likely the import carrier to
recognize the 38 amino acid NLS located at the N-terminal sequence
of polo box I. Since it is reasonable to expect that the 38 amino acid
NLS lacks the substrate-binding capability of the complete PBD, the
experimental evidence suggested that the 38 amino acid sequence
located at the polo box I of the PBD facilitates nuclear import of Plk1
through recruiting transportin directly.
4. Discussion
This study was initiated by the observation that deletion of the
four amino acids in the polo box domain resulted in apparent
cytoplasmic accumulation of Plk1. We discovered that the PBD is able
to direct nuclear import in vivo and in vitro and that transportin and
importin α interact directly with the PBD in a Ran–GTP sensitive
manner. A 38 amino acid sequence, including the four amino acids
deleted in the ΔKWVD mutation or changed to alanine in the
KWVD4A mutation, is sufﬁcient to direct nuclear import, indicating
that this 38 amino acid sequence is an NLS. These ﬁndings suggest that
the PBD facilitates nuclear transport of Plk1 by recruiting import
carriers and not by tethering to another nuclear protein. In addition, it
appears that the bipartite NLS in the kinase domain and this newly-
identiﬁed NLS located in the PBD may contribute differently to the
import efﬁciency throughout the cell cycle. It was reported that the
importin α–β complex has lower import efﬁciency at the early S
phase [34], possibly contributing to our observation on the similar
nucleocytoplasmic distribution of WT and ΔKD in the cells under
double thymidine block (Fig. 2). The importin α–β complex possibly
Fig. 6. The 38 amino acid NLS with NLS function is recognized by transportin. (A) The schematic depicts the structures of FLAG-38-β-gal. (B) HeLa cells expressing FLAG-β-gal (lanes
1 and 2) and FLAG-38-β-gal (lanes 3 and 4) were fractionated into the nuclear (lanes 1 and 3) and cytoplasmic (lanes 2 and 4) fractions. The extracts were subject to immunoblotting
with an anti-β-galactosidase antibody. (C) HeLa cells expressing FLAG-β-gal (panel A) and FLAG-38-β-gal (panel C) were subject to indirect ﬂuorescence immunostaining with an
anti-β-galactosidase antibody. The nuclei were stained with DAPI (panels B and D). (D) Recombinant GST (lanes 2 and 6), GST–importin α (lanes 3 and 7), and GST–transportin
(lanes 4 and 8) were used to precipitate FLAG-β-gal (lanes 1 to 4) or FLAG-38-β-gal (lanes 5 to 8) expressed in HEK293 cells. Matrix-bound proteins were subjected to
immunoblotting using an anti-β-galactosidase antibody (top panel). The bait proteins were visualized by staining the membrane with Coomassie blue R-250 (middle and bottom
panels). Ten percent of the cell extracts used in the pull-down assay are shown (lanes 1 and 5).
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released from the blocks, resulting in higher nuclear localization of
WT Plk1 by the time the cells were ready to enter mitosis.
The result that transportin interacts with the 38 amino acid NLS
strongly suggests that transportin is the authentic import carrier
recognizing this NLS. In contrast to transportin, the function of
importin α in nuclear import of the PBD is less clear. Although
importinα is able to interact with PBD in a Ran–GTP sensitivemanner,
lacking the evidence demonstrating the association of importin βwith
the PBD implies that the interaction between importin α and the PBD
may not be involved in mediating the nuclear import of Plk1. Instead,
it is possible that importin α is phosphorylated by Plk1 that
recognizes its substrate through the PBD. Alternatively, importin α
could still play a role in the PBD-mediated nuclear import, possibly
functioning redundantly to transportin. The trace amount of 38-β-gal
pulled downed by importin α (Fig. 6C) lends some evidence to this
notion. This data also indicated that the 38 amino acid sequence is not
the optimal NLS preferred by importin α. In any case, further study is
required in order to clarify the role of importin α.
The prototype of the NLS recognized by transportin is the M9
sequence of hnRNP A1. The consensus transportin-recognized NLS
deduced from the structure of the transportin-M9 complex is a central
hydrophobic or basic motif followed by a C-terminal R/H/KX(2–5)PY
sequence [35]. These speciﬁc motifs are not present in the NLS weidentiﬁed in this study. Moreover, it was shown previously that the
transportin-bound M9 sequence displays a disordered secondary
structure [35], while the NLS reported in the present study is part of
the overall structure of the PBD [4,5]. Hence, the putative 38 amino acid
NLS exhibits low homology to theM9 sequence and possibly represents
a novel NLS recognized by transportin. The ﬁnding described in this
report demonstrates the versatility of transportin and potentially
expands our understanding of how transportin recognizes its cargos.
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